These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 19422539

  • 1. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A, Yamazaki T, Lemere CA, Takatama M, Okamoto K.
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [Abstract] [Full Text] [Related]

  • 2. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
    Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW.
    Ann Neurol; 2007 May; 61(5):435-45. PubMed ID: 17469117
    [Abstract] [Full Text] [Related]

  • 3. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease.
    Hu WT, Josephs KA, Knopman DS, Boeve BF, Dickson DW, Petersen RC, Parisi JE.
    Acta Neuropathol; 2008 Aug; 116(2):215-20. PubMed ID: 18592255
    [Abstract] [Full Text] [Related]

  • 4. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, Togo T, Katsuse O, Uchikado H, Furukawa Y, Kosaka K, Arai H.
    Brain Res; 2007 Dec 12; 1184():284-94. PubMed ID: 17963732
    [Abstract] [Full Text] [Related]

  • 5. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin.
    Hiji M, Takahashi T, Fukuba H, Yamashita H, Kohriyama T, Matsumoto M.
    Acta Neuropathol; 2008 Aug 12; 116(2):183-91. PubMed ID: 18584184
    [Abstract] [Full Text] [Related]

  • 6. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM, Trojanowski JQ, Neumann M.
    J Neuropathol Exp Neurol; 2008 Jun 12; 67(6):555-64. PubMed ID: 18520774
    [Abstract] [Full Text] [Related]

  • 7. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
    King A, Maekawa S, Bodi I, Troakes C, Al-Sarraj S.
    Neuropathology; 2011 Jun 12; 31(3):239-49. PubMed ID: 21118398
    [Abstract] [Full Text] [Related]

  • 8. Phosphorylation-dependent TDP-43 antibody detects intraneuronal dot-like structures showing morphological characters of granulovacuolar degeneration.
    Kadokura A, Yamazaki T, Kakuda S, Makioka K, Lemere CA, Fujita Y, Takatama M, Okamoto K.
    Neurosci Lett; 2009 Sep 29; 463(1):87-92. PubMed ID: 19539703
    [Abstract] [Full Text] [Related]

  • 9. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.
    Smith VD, Bachstetter AD, Ighodaro E, Roberts K, Abner EL, Fardo DW, Nelson PT.
    Brain Pathol; 2018 Mar 29; 28(2):264-273. PubMed ID: 28281308
    [Abstract] [Full Text] [Related]

  • 10. TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
    Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, Van Deerlin VM, Clark CM, Grossman M, Miller BL, Trojanowski JQ, Lee VM.
    J Neuropathol Exp Neurol; 2007 Mar 29; 66(3):177-83. PubMed ID: 17356379
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease.
    Fujishiro H, Uchikado H, Arai T, Hasegawa M, Akiyama H, Yokota O, Tsuchiya K, Togo T, Iseki E, Hirayasu Y.
    Acta Neuropathol; 2009 Feb 29; 117(2):151-8. PubMed ID: 19039597
    [Abstract] [Full Text] [Related]

  • 14. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease.
    Rohn TT.
    Brain Res; 2008 Sep 04; 1228():189-98. PubMed ID: 18634762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T.
    Neuropathology; 2018 Feb 04; 38(1):72-81. PubMed ID: 28960544
    [Abstract] [Full Text] [Related]

  • 18. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M, Riascos D, Kovalik T, An J, Krupa K, Krupa K, Hood BL, Conrads TP, Renton AE, Traynor BJ, Bowser R.
    Acta Neuropathol; 2012 Nov 04; 124(5):717-32. PubMed ID: 22993125
    [Abstract] [Full Text] [Related]

  • 19. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, Baker MC, Boylan KB, Rademakers R, Dickson DW.
    Acta Neuropathol; 2013 Feb 04; 125(2):289-302. PubMed ID: 23053135
    [Abstract] [Full Text] [Related]

  • 20. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
    Takeda T, Uchihara T, Arai N, Mizutani T, Iwata M.
    Acta Neuropathol; 2009 Jan 04; 117(1):35-44. PubMed ID: 19002475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.